Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash from Operations (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Cash from Operations for 5 consecutive years, with 3803000.0 as the latest value for Q4 2020.

  • Quarterly Cash from Operations fell 482.39% to 3803000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 18423000.0 through Dec 2020, down 564.85% year-over-year, with the annual reading at 50900000.0 for FY2025, 65.56% down from the prior year.
  • Cash from Operations for Q4 2020 was 3803000.0 at Forte Biosciences, up from 7739000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 16117000.0 in Q2 2019, with the low at 17682000.0 in Q1 2019.
  • Average Cash from Operations over 5 years is 5816750.0, with a median of 7460000.0 recorded in 2017.
  • The sharpest move saw Cash from Operations skyrocketed 249.74% in 2019, then crashed 1299.46% in 2020.
  • Over 5 years, Cash from Operations stood at 7748000.0 in 2016, then decreased by 18.38% to 9172000.0 in 2017, then tumbled by 30.21% to 11943000.0 in 2018, then surged by 94.53% to 653000.0 in 2019, then plummeted by 482.39% to 3803000.0 in 2020.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 3803000.0, 7739000.0, and 4016000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.